ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Carnegie Mellon President Emeritus honored By UPCI; Schiffer Leaves Maryland for Detroit

October 17, 1997

In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators

June 3, 1994

Report Questions Effectiveness Of Bimanual Pelvic Exam

March 31, 2006

Miami Core Grant Not Renewed, Status Threatened

September 21, 1990

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982